Circumcision, hemophilia, and being healthy in developing countries [1]

Pediatric Hematology and Oncology

Volumn 18, Issue 6, 2001, Pages 419-420

  Kavakli, K ^a   Nisli G ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; CORTICOSTEROID; FIBRIN GLUE; FRESH FROZEN PLASMA;

BLEEDING; CIRCUMCISION; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CULTURAL FACTOR; DEVELOPING COUNTRY; DRUG COST; HEALTH CARE COST; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JEW; LETTER; MONEY; MOSLEM; SOCIAL ASPECT; VIRUS TRANSMISSION;

ADRENAL CORTEX HORMONES; BLOOD TRANSFUSION; CIRCUMCISION, MALE; DEVELOPING COUNTRIES; FIBRIN TISSUE ADHESIVE; HEMOPHILIA A; HUMANS; MALE; PLASMA; TURKEY;

EID: 0034830536     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101316922056     Document Type: Letter

References (7)

1. How hemophiliacs could be circumcised in developing countries
2. Should hemophiliac patients be circumcised?
3. Circumcision and haemophilia: A perspective
4. Safer circumcision in patients with haemophilia: The use of fibrin glue for local haemostasis
5. Circumcision in hemophilia: The use of fibrin glue for local hemostasis
6. Fibrin glue and clinical impact on haemophilia care
7. Hepatitis C virus and the treatment of hemophilia in Turkey